Connect with us
Information

Australia
North America
World

Investing News NetworkYour trusted source for investing success

North America
Australia
World
My INN

Private Placements

Reports & Guides
- Market Outlook Reports
- Investing Guides

Precious Metals
Battery Metals
Base Metals
Energy
Critical Metals

amicus therapeutics

POPULAR ARTICLES

An Investor’s Guide to Clinical Trials

An Investor’s Guide to Clinical Trials

Amicus Therapeutics Announces First Patient Dosed in Phase 3 PROPEL Pivotal Study of AT-GAA in Patients with Pompe Disease

Amicus Therapeutics Announces Regulatory and Clinical Updates for AT-GAA in Pompe Disease

LATEST ARTICLES

Pharmaceutical Investing

Amicus Therapeutics Announces Approval of Galafold® (Migalastat) for Fabry Disease in Japan

Amicus Therapeutics Announces Full-Year 2017 Financial Results and 2018 Corporate Updates

Amicus Therapeutics Prices Underwritten Offering of Common Stock

Amicus Therapeutics Announces Public Offering of Common Stock

U.S. FDA Files New Drug Application Under Priority Review for Migalastat for Treatment of Fabry Disease

Canadian Drug Expert Committee Grants Positive Recommendation for Reimbursement of Galafold

Amicus Therapeutics Launches Treatment of Fabry Disease in Spain

Biotech Investing

The Case for Investing in Biotech

Latest News

Opawica Explorations Inc Announces the Closing of Non-Brokered Private Placement

RUA GOLD Begins Drilling at Cumberland Target in the Reefton Goldfield, Following up on a 20.7m Intercept of 62g/t Gold

Cizzle Brands' CWENCH Hydration Becomes USA Hockey's Official Hydration Partner

Los Andes Copper Announces Expansion of Land Package

Blackstone Unlocks High Grade Copper-Gold at Mankayan